双膦酸盐与帕金森病患者骨折率降低相关
该回顾性队列研究基于韩国国民健康保险服务数据库2002至2018年近全体人群数据,从608202例帕金森病患者中选取7335例进入索引回归模型、5806例进入骨质疏松诊断后1年landmark模型。Landmark模型显示双膦酸盐使用对骨质疏松性骨折有显著预防效果(HR 0.83,95%CI 0.73-0.96,p=0.012),较高年龄、大量饮酒、吸烟及实体瘤病史为显著危险因素,较高体重为显著保护因素。
要点
- 双膦酸盐使用与帕金森病患者骨质疏松性骨折风险降低显著相关(HR 0.83)。
- 较高年龄、大量饮酒、吸烟及实体瘤病史是骨折的显著危险因素。
- 较高体重为骨质疏松性骨折的显著保护因素。
核心结论
- 在帕金森病合并骨质疏松患者中,双膦酸盐使用对骨质疏松性骨折具有显著预防效果(HR 0.83,95%CI 0.73-0.96,p=0.012)。
研究设计与样本
- 回顾性队列研究,使用韩国国民健康保险服务2002至2018年数据库,覆盖近全体韩国人群。
- 从608202例帕金森病患者中选取7335例进入索引回归模型,另选5806例进入骨质疏松诊断后1年landmark模型。
主要发现
- Landmark模型显示双膦酸盐使用显著降低骨质疏松性骨折风险(HR 0.83,95%CI 0.73-0.96,p=0.012)。
- 索引回归模型中较高年龄、较大腰围、吸烟及淋巴瘤病史为骨质疏松性骨折的显著危险因素。
- 索引回归模型中较高体重和较高体力活动评分为显著保护因素。
- Landmark模型(5806例)中较高年龄、大量饮酒、吸烟及实体瘤病史为显著危险因素,较高体重为显著保护因素。
关键数值与推荐
- 双膦酸盐使用与骨质疏松性骨折风险的HR为0.83(95%CI 0.73-0.96,p=0.012),基于骨质疏松诊断后1年landmark模型。
临床怎么用
- 对帕金森病合并骨质疏松患者,可考虑使用双膦酸盐以降低骨质疏松性骨折风险。
- 评估骨折风险时应关注较高年龄、大量饮酒、吸烟及肿瘤病史等危险因素,并注意较高体重可能具有保护作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients with Parkinson's disease, often accompanied by osteoporosis, have a higher risk of osteoporotic fractures. However, a large cohort study assessing the preventive effect of bisphosphonates for osteoporotic fracture on patients with Parkinson's disease is scarce. METHODS: This retrospective cohort study included nearly whole population of South Korea during 2002 to 2018 from the national patient database of Korea National Health Insurance Service. Of 608,202 patients with Parkinson's disease, a total of 7335 patients were selected for index regression model and 5806 patients were further selected for landmark model of 1 year after diagnosis of osteoporosis. Occurrence of osteoporotic fracture was set defined as outcome variable for both regression models. RESULTS: Regression analysis with a landmark model one year after the index diagnosis of osteoporosis showed that the use of bisphosphonates had a significant preventive effect on osteoporotic fractures (hazard ratio [HR] 0.83, 95% confidence interval [CI] 0.73-0.96, p = 0.012). In index regression model, higher age, larger waist circumference, smoking, and history of lymphoma were significant risk factors of osteoporotic fractures. Higher weight and higher physical activity score were significant preventative factors. CONCLUSION: In the regression analysis with landmark model with 5806 patients, higher age, heavy alcohol consumption, smoking, and history of solid tumor were significant risk factors of osteoporotic fractures. Higher weight was a significant preventative factor.
引用
- Jang MU, Kim MS, Hwang J, et al. Bisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson's disease. Osteoporos Int. 2026. PMID: 41724829. doi:10.1007/s00198-026-07906-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。